{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:03:03Z","timestamp":1789459383752,"version":"build-2803163510"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s10741-007-9006-5","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T16:55:31Z","timestamp":1175187331000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Renal dysfunction in heart failure patients: what is the evidence?"],"prefix":"10.1007","volume":"12","author":[{"given":"Heath E.","family":"Saltzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Joshua","family":"Whellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,29]]},"reference":[{"key":"9006_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield MM, Jacobsen SJ, Burnett JC et al (2003) Burden of systolic and diastolic dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194\u2013202","journal-title":"JAMA"},{"key":"9006_CR2","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068\u20133072","journal-title":"Circulation"},{"key":"9006_CR3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","volume":"44","author":"J Ezekowitz","year":"2004","unstructured":"Ezekowitz J, McAlister FA, Humphries KH et al (2004) the association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44:1587\u20131592","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0735-1097(99)00608-7","volume":"35","author":"DL Dries","year":"2000","unstructured":"Dries DL, Exner DV, Domanski MJ et al (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681\u2013689","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR5","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1097\/01.ASN.0000018409.45834.FA","volume":"13","author":"WM McClellan","year":"2002","unstructured":"McClellan WM, Flanders WD, Langston RD et al (2002) Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 13:1928\u20131936","journal-title":"J Am Soc Nephrol"},{"key":"9006_CR6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","volume":"137","author":"MG Shilpak","year":"2002","unstructured":"Shilpak MG, Heidenreich PA, Noguchi H et al (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555\u2013562","journal-title":"Ann Intern Med"},{"key":"9006_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1053\/ajkd.2001.24522","volume":"37","author":"JN Beattie","year":"2001","unstructured":"Beattie JN, Soman SS, Sandberg KR et al (2001) Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37:1191\u20131200","journal-title":"Am J Kidney Dis"},{"key":"9006_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285\u20131295","journal-title":"N Engl J Med"},{"key":"9006_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1067\/mhj.2002.125504","volume":"144","author":"GR Walsh","year":"2002","unstructured":"Walsh GR, O\u2019Donnell CJ, Camargo CA et al (2002) Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144:1003\u20131011","journal-title":"Am Heart J"},{"key":"9006_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","volume":"41","author":"G Manjunath","year":"2003","unstructured":"Manjunath G, Tighiouart H, Ibrahim H et al (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47\u201355","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0735-1097(03)00163-3","volume":"41","author":"LF Fried","year":"2003","unstructured":"Fried LF, Shilpak MG, Crump C et al (2003) Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41:1364\u20131372","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","volume":"134","author":"JF Mann","year":"2001","unstructured":"Mann JF, Gerstein HC, Pogue J et al (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramapril: the HOPE randomized trial. Ann Intern Med 134:629\u2013636","journal-title":"Ann Intern Med"},{"key":"9006_CR13","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305","journal-title":"N Engl J Med"},{"key":"9006_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"HL Hillege","year":"2000","unstructured":"Hillege HL, Armand RJ, Girbes MD et al (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203\u2013210","journal-title":"Circulation"},{"key":"9006_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","volume":"38","author":"A Al-Ahmad","year":"2001","unstructured":"Al-Ahmad A, Rand WM, Manjunath G et al (2001) Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38:955\u2013962","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0735-1097(02)02125-3","volume":"40","author":"NG Mahon","year":"2002","unstructured":"Mahon NG, Blackstone EH, Francis GS et al (2002) The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40:1106\u20131113","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/S0735-1097(02)02490-7","volume":"40","author":"MT Kearney","year":"2002","unstructured":"Kearney MT, Fox KA, Lee AJ et al (2002) Predicting death due to progressive heart failure in patients with mild to moderate chronic heart disease. J Am Coll Cardiol 40:1801\u20131808","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0735-1097(02)02125-3","volume":"40","author":"MG Niall","year":"2002","unstructured":"Niall MG, Blackstone EH, Francis GS et al (2002) The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40:1106\u20131113","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2004.07.040","volume":"44","author":"K Bibbins-Domingo","year":"2004","unstructured":"Bibbins-Domingo K, Lin F, Vittinghoff E et al (2004) Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 44:1593\u20131600","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","volume":"109","author":"FA McAlister","year":"2004","unstructured":"McAlister FA, Ezekowitz J, Tonelli M et al (2004) Renal insufficiency and heart failure. Prognostic and therapeutic implications from a prospective cohort study. Circulation 109:1004\u20131009","journal-title":"Circulation"},{"key":"9006_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2369-7-3","volume":"7","author":"J Luthi","year":"2006","unstructured":"Luthi J, Flanders WD, Burnier M et al (2006) Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients. BMC Nephrol 7:3","journal-title":"BMC Nephrol"},{"key":"9006_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0002-9149(03)00822-1","volume":"92","author":"CU Chae","year":"2003","unstructured":"Chae CU, Albert CM, Glynn RJ et al (2003) Mild renal insufficiency and risk of congestive heart failure in men and women\u00a0\u2265\u00a070\u00a0years of age. Am J Cardiol 92:682\u2013686","journal-title":"Am J Cardiol"},{"key":"9006_CR23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","volume":"137","author":"MG Shlipak","year":"2002","unstructured":"Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM et al (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555\u2013562","journal-title":"Ann Intern Med"},{"key":"9006_CR24","first-page":"295","volume":"325","author":"SOLVD The","year":"1991","unstructured":"The SOLVD investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:295\u2013302","journal-title":"N Engl J Med."},{"key":"9006_CR25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"SOLVD The","year":"1992","unstructured":"The SOLVD investigators (1992) Effect of enalapril on mortality, the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685\u2013691","journal-title":"N Engl J Med"},{"key":"9006_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"9006_CR27","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L Kober","year":"1995","unstructured":"Kober L, Torp-Pederson C, Carlsen JE et al (1995) A clinical trial of the angiotensin-converting\u2013enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolopril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333:1670\u20131676","journal-title":"N Engl J Med"},{"key":"9006_CR28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","unstructured":"The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1429\u20131435","journal-title":"N Engl J Med."},{"key":"9006_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","volume":"349","author":"B Pit","year":"1997","unstructured":"Pit B, Segal R, Martinez FA et al (1997) Randomized trail of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349:747\u2013752","journal-title":"Lancet"},{"key":"9006_CR30","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","volume":"355","author":"B Pitt","year":"2000","unstructured":"Pitt B, Poole-Wilson PA, Segal R et al (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial \u2013 the Losartan Heart Failure Survival Study ELITE II. Lancet 355:1582\u20131587","journal-title":"Lancet"},{"key":"9006_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"JN Cohn","year":"2001","unstructured":"Cohn JN, Tognoni G (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667\u20131675","journal-title":"N Engl J Med"},{"key":"9006_CR32","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ et al (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893\u20131906","journal-title":"N Engl J Med"},{"key":"9006_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, Swedberg K, Granger CB et al (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362:759\u2013766","journal-title":"Lancet"},{"key":"9006_CR34","doi-asserted-by":"crossref","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial (1999) Lancet 353:9\u201313","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"9006_CR35","doi-asserted-by":"crossref","unstructured":"Randomized, placebo \u2013controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease (1997) Australia\/New Zealand Heart Failure Research Collaborative Group. Lancet 349:375\u2013380","DOI":"10.1016\/S0140-6736(97)80008-6"},{"key":"9006_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJ, Fowler MB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:709\u2013717","journal-title":"N Engl J Med"},{"key":"9006_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN et al (1996) The effects of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. carvediliol heart failure Study Group. N Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"key":"9006_CR38","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","volume":"283","author":"A Hjalmarson","year":"2000","unstructured":"Hjalmarson A, Goldstein S, Fagerberg B et al (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The Metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). JAMA 283:1295\u20131302","journal-title":"JAMA"},{"key":"9006_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"9006_CR40","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"P Bertram","year":"2003","unstructured":"Bertram P, Remme W, Zannad F et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"key":"9006_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"The Digitalis Investigation Group","year":"1997","unstructured":"The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525\u2013533","journal-title":"N Engl J Med"},{"key":"9006_CR42","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","volume":"352","author":"P Ruggenenti","year":"1998","unstructured":"Ruggenenti P, Perna A, Gherardi G et al (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long term ramapril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramapril Efficacy in Nephropathy. Lancet 352:1252\u20131256","journal-title":"Lancet"},{"key":"9006_CR43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","volume":"354","author":"P Ruggenenti","year":"1999","unstructured":"Ruggenenti P, Perna A, Gherardi G et al (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic protienuria. Lancet 354:359\u2013364","journal-title":"Lancet"},{"key":"9006_CR44","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa042167","volume":"351","author":"P Ruggenenti","year":"2004","unstructured":"Ruggenenti P, Fassi A, Illieva AP et al (2004) Preventing microalbuminuria in type 2 diabetics. N Engl J Med 351:1941\u20131951","journal-title":"N Engl J Med"},{"key":"9006_CR45","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis EJ, Hunsicker LG, Bain RP et al (1993) The effect of angiotensin\u2013converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456\u20131462","journal-title":"N Engl J Med"},{"key":"9006_CR46","doi-asserted-by":"publisher","first-page":"40D","DOI":"10.1016\/0002-9149(90)90475-G","volume":"66","author":"K Swedberg","year":"1990","unstructured":"Swedberg K, Eneroth P, Kjekshus J et al (1990) Effects of enalapril and neuroendocrine activation on the prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group. Am J Cardiol 66:40D\u201344D","journal-title":"Am J Cardiol"},{"key":"9006_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0002-9149(92)91194-9","volume":"70","author":"S Ljungman","year":"1992","unstructured":"Ljungman S, Kjekshus J, Swedberg K (1992) Renal function I severe congestive heart failure during treatment with enalapril (the cooperative North Scandinavian Enalapril Survival Study. [CONSENSUS] trial). Am J Cardiol 70:479\u2013487","journal-title":"Am J Cardiol"},{"issue":"Suppl 4","key":"9006_CR48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","volume":"39","author":"S Ljungman","year":"1990","unstructured":"Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39 (Suppl 4):10\u201321","journal-title":"Drugs"},{"key":"9006_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archinte.161.2.165","volume":"61","author":"BM Massie","year":"2001","unstructured":"Massie BM, Armstrong PW, Cleland JG et al (2001) Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The assessment of treatment with lisinopril and survival. Arch Intern Med 61:165\u2013171","journal-title":"Arch Intern Med"},{"key":"9006_CR50","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M, Pool-Wilson PA, Armstrong PW et al (1999) Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure. The ATLAS Study Group. Circulation 100:2312\u20132318","journal-title":"Circulation"},{"key":"9006_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"H Parving","year":"2001","unstructured":"Parving H, Lehnert H, Brochner-Mortensen J et al (2001) Irbesartan in patients with type 2 diabetes and microalbuminuria study group: the effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870\u2013878","journal-title":"N Engl J Med"},{"key":"9006_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1071-9164(99)90038-6","volume":"5","author":"JN Cohn","year":"1999","unstructured":"Cohn JN, Tognoni G, Glazer RD et al (1999) Rationale and design of the valsartan heart failure trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Card Fail 5:155\u2013160","journal-title":"J Card Fail"},{"key":"9006_CR53","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.88.4.1610","volume":"88","author":"HL Haber","year":"1993","unstructured":"Haber HL, Simek CL, Gimple LW et al (1993) Why do patients with congestive heart failure tolerate the initiation of beta blocker therapy? Circulation 88:1610\u20131619","journal-title":"Circulation"},{"key":"9006_CR54","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/0735-1097(94)00543-Y","volume":"25","author":"SA Hall","year":"1995","unstructured":"Hall SA, Cigarroa CG, Marcoux L et al (1995) Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 25:1154\u20131161","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR55","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.CIR.102.5.546","volume":"102","author":"M Metra","year":"2000","unstructured":"Metra M, Giubbini R, Nodari S et al (2000) Differential effects of beta-blocker in patients with heart failure: a prospective, double-blind comparison of the long term effects of metoprolol versus carvedilol. Circulation 102:546\u2013551","journal-title":"Circulation"},{"key":"9006_CR56","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/0735-1097(95)00012-S","volume":"25","author":"SL Olsen","year":"1995","unstructured":"Olsen SL, Gilbert EM, Renlund DG et al (1995) Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol 25:1225\u20131231","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.CIR.102.5.546","volume":"102","author":"M Metra","year":"2000","unstructured":"Metra M, Giubbini R, Nodari S et al (2000) Differential effects of beta-blockers in patients with heart failure: a prospective, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 102:546\u2013551","journal-title":"Circulation"},{"key":"9006_CR58","doi-asserted-by":"crossref","first-page":"54J","DOI":"10.1016\/S0002-9149(97)00841-2","volume":"80","author":"The International Steering Committee on Behalf of the MERIT-HF Study Group","year":"1997","unstructured":"The International Steering Committee on Behalf of the MERIT-HF Study Group (1997) Rationale, Design, and Organization of the Metoprolol CR\/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). Am J Cardiol. 80:54J\u201358J","journal-title":"Am J Cardiol."},{"key":"9006_CR59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMra035279","volume":"351","author":"BF Palmer","year":"2004","unstructured":"Palmer BF (2004) Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 351:585\u2013592","journal-title":"N Engl J Med"},{"key":"9006_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","volume":"46","author":"B Pitt","year":"2005","unstructured":"Pitt B, White H, Nicolau J et al (2005) Eplerenone reduces mortality 30\u00a0days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 46:425\u2013431","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"EM Antman","year":"2004","unstructured":"Antman EM et al (2004) Report of the American College of cardiology\/American heart association task force on practice guidelines (Writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 44:671\u2013719","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR62","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","volume":"15","author":"MG Shlipak","year":"2004","unstructured":"Shlipak MG, Smith GL, Rathore SS et al (2004) Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trail. J Am Soc Nephrol 15:2195\u20132203","journal-title":"J Am Soc Nephrol"},{"key":"9006_CR63","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","volume":"8","author":"SS Gottlieb","year":"2002","unstructured":"Gottlieb SS, Abraham W, Butler J et al (2002) The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8:136\u2013141","journal-title":"J Card Fail"},{"issue":"suppl 7","key":"9006_CR64","first-page":"S21","volume":"4","author":"for the ADHERE Scientific Advisory Committee","year":"2003","unstructured":"Fonarow GC, for the ADHERE Scientific Advisory Committee (2003) The Acute Decompensated Heart Failure National Registry (ADHERE): Opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4(suppl 7):S21\u2013S30","journal-title":"Rev Cardiovasc Med"},{"key":"9006_CR65","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S0002-9149(00)00705-0","volume":"85","author":"HM Krumholz","year":"2000","unstructured":"Krumholz HM, Chen Y, Vaccarine V et al (2000) Correlates and impact on outcomes of worsening renal function in patients > 65\u00a0years of age with heart failure. Am J Cardiol 85:1110\u20131113","journal-title":"Am J Cardiol"},{"key":"9006_CR66","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","volume":"147","author":"J Butler","year":"2004","unstructured":"Butler J, Forman DE, Abraham WT et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147:331\u2013338","journal-title":"Am Heart J"},{"key":"9006_CR67","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1161\/01.CIR.0000141829.04031.25","volume":"110","author":"DJ Wang","year":"2004","unstructured":"Wang DJ, Dowling TC, Meadows D et al (2004) Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110:1620\u20131625","journal-title":"Circulation"},{"key":"9006_CR68","first-page":"1531","volume":"287","author":"Publication Committee for the VMAC Investigators","year":"2002","unstructured":"Publication Committee for the VMAC Investigators (2002) Intravenous nesiritide vs nitroglycerin for treatment of decompensated heart failure. A randomized controlled trial. JAMA. 287:1531\u20131540","journal-title":"JAMA."},{"key":"9006_CR69","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","volume":"293","author":"JD Sackner-Bernstein","year":"2005","unstructured":"Sackner-Bernstein JD, Kowalski M, Fox M et al (2005) Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293:1900\u20131905","journal-title":"JAMA"},{"key":"9006_CR70","doi-asserted-by":"crossref","unstructured":"Iglesias J, Hom D, Antoniotti et al (2006) Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). Nephrol Dial Transplant 21:3458\u20133465","DOI":"10.1093\/ndt\/gfl428"},{"key":"9006_CR71","unstructured":"Milrinone Lactate package insert. Bedford Labratories, June 2005"},{"key":"9006_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-8703(00)90303-X","volume":"139","author":"MS Cuffe","year":"2000","unstructured":"Cuffe MS, Califf RM, Adams KF et al (2000) Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J 139:15\u201322","journal-title":"Am Heart J"},{"key":"9006_CR73","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams KF et al (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure. A randomized controlled trial. JAMA 287:1541\u20131547","journal-title":"JAMA"},{"key":"9006_CR74","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","volume":"46","author":"BA Bart","year":"2005","unstructured":"Bart BA, Boyle A, Bank AJ et al (2005) Ultrafiltration versus usual care for hospitalized patients with heart failure: the relief for acutely fluid-overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol 46:2043\u20132046","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR75","unstructured":"Constanzo MR, for the UNLOAD Investigators (2006) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure: the UNLOAD trial. Presented at: ACC 55th Annual Scientific Session; GA: March 11\u201314, 2006"},{"key":"9006_CR76","first-page":"2A","volume":"39","author":"I Iakovou","year":"2002","unstructured":"Iakovou I, Dangas G, Lansky AJ et al (2002) Incidence, predictors, and economic impact of contrast induced nephropathy: results in 8,628 patients treated with percutaneous coronary interventions. J Am Coll Cardiol 39:2A","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR77","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/S0735-1097(00)00917-7","volume":"36","author":"L Gruberg","year":"2000","unstructured":"Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48\u00a0h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542\u20131548","journal-title":"J Am Coll Cardiol"},{"key":"9006_CR78","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","volume":"105","author":"C Rihal","year":"2002","unstructured":"Rihal C, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259\u20132264","journal-title":"Circulation"},{"key":"9006_CR79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","volume":"95","author":"G Dangas","year":"2005","unstructured":"Dangas G, Iakovou I, Nikolsky E et al (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13\u201319","journal-title":"Am J Cardiol"},{"key":"9006_CR80","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","volume":"294","author":"The ESCAPE Investigators and the ESCAPE Study Coordinators","year":"2005","unstructured":"The ESCAPE Investigators and the ESCAPE Study Coordinators (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness. JAMA 294:1625\u20131633","journal-title":"JAMA"},{"key":"9006_CR81","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:224\u2013237","journal-title":"N Engl J Med"},{"key":"9006_CR82","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrilllator in advanced chronic heart failure. N Engl J Med 350:2140\u20132150","journal-title":"N Engl J Med"},{"key":"9006_CR83","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1054\/jcaf.2000.9501","volume":"6","author":"MR Bristow","year":"2000","unstructured":"Bristow MR, Feldman AM, Saxon LA et al (2000) Heart failure management using implantable devices for ventricular resynchronization: comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 6:276\u2013285","journal-title":"J Card Fail"},{"key":"9006_CR84","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877\u2013883","journal-title":"N Engl J Med"},{"key":"9006_CR85","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ahj.2005.06.042","volume":"151","author":"H Hreybe","year":"2006","unstructured":"Hreybe H, Ezzeddine R, Bedi M et al (2006) Renal insufficiency predicts the time to the first appropriate defibrillator shock. Am Heart J 151:852\u2013856","journal-title":"Am Heart J"},{"key":"9006_CR86","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/archinte.165.7.790","volume":"165","author":"A Corsonello","year":"2005","unstructured":"Corsonello A et al (2005) Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 165:790\u2013795","journal-title":"Arch Intern Med"},{"key":"9006_CR87","unstructured":"National Kidney Foundation. Kidney disease outcomes quality initiative. Clinical practice guidelines [http:\/\/www.kidney.org\/professionals\/kdoqi\/guidelines.cfm]"},{"key":"9006_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000130554","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31\u201341","journal-title":"Nephron"},{"key":"9006_CR89","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"9006_CR90","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archinte.160.5.685","volume":"160","author":"A Ahmed","year":"2000","unstructured":"Ahmed A (2000) Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? Arch Intern Med 160:685\u2013693","journal-title":"Arch Intern Med"},{"key":"9006_CR91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","volume":"354","author":"FF Hou","year":"2006","unstructured":"Hou FF, Zhang X, Zhang GH et al (2006) Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354:131\u2013140","journal-title":"N Engl J Med"},{"key":"9006_CR92","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1001\/archinte.160.17.2645","volume":"160","author":"CD Frances","year":"2000","unstructured":"Frances CD, Noguchi H, Massie BM et al (2000) Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch Intern Med 160:2645\u20132650","journal-title":"Arch Intern Med"},{"key":"9006_CR93","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/CIRCULATIONAHA.105.592733","volume":"114","author":"SD Solomon","year":"2006","unstructured":"Solomon SD, Rice MM, Jablonski KA et al (2006) Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the prevention of events with ACE inhibition (PEACE) trial. Circulation 114:26\u201331","journal-title":"Circulation"},{"key":"9006_CR94","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ncpcardio0433","volume":"3","author":"CM Wyatt","year":"2006","unstructured":"Wyatt CM, Kim MC, Winston JA (2006) Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing. Nat Clin Pract Cardiovasc Med 3:102\u2013109","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"9006_CR95","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJMe058295","volume":"354","author":"Herbert","year":"2006","unstructured":"Herbert LA (2006) Optimizing ACE-inhibitor therapy for chronic kidney disease. N Engl J Med 354:189\u2013191","journal-title":"N Engl J Med"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-007-9006-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9006-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T05:15:05Z","timestamp":1652850905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-007-9006-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9006"],"URL":"https:\/\/doi.org\/10.1007\/s10741-007-9006-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"20 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}